D. A. Dart

发表

microRNA 1307 Is a Potential Target for SARS-CoV-2 Infection: An in Vitro Model

G. Grant, E. Arısan, S. Lange, 2022, ACS omega.

Antiandrogens Act as Selective Androgen Receptor Modulators at the Proteome Level in Prostate Cancer Cells

S. Gamble, R. Wait, J. Waxman, 2015, Molecular & Cellular Proteomics.

Androgens have Forgotten and Emerging Roles Outside of their Reproductive Functions, with Implications for Diseases and Disorders

D. Dart, D. A. Dart, 2014 .

MiR-221 Is Specifically Elevated in PC3 Cells and its Deletion Reduces Adhesion, Motility and Growth

Wenguo Jiang, S. Koushyar, D. A. Dart, 2019, AntiCancer Research.

Visualising Androgen Receptor Activity in Male and Female Mice

E. Aboagye, J. Waxman, C. Bevan, 2013, PloS one.

Insights into roles of the miR-1, -133 and -206 family in gastric cancer (Review).

J. Ji, Wenguo Jiang, X. Wen, 2016, Oncology reports.

Interplay between steroid signalling and microRNAs: implications for hormone-dependent cancers.

C. Fletcher, C. Bevan, D. A. Dart, 2014, Endocrine-related cancer.

In Vivo Imaging of Nuclear Receptor Transcriptional Activity.

C. Bevan, D. A. Dart, 2016, Methods in molecular biology.

Androgen receptor-modulatory microRNAs provide insight into therapy resistance and therapeutic targets in advanced prostate cancer

S. McGuire, X. Gidrol, D. Leach, 2019, Oncogene.

The prohibitin-repressive interaction with E2F1 is rapidly inhibited by androgen signalling in prostate cancer cells

W. Jiang, W. Jiang, S. Zaat, 2017, Oncogenesis.

Unveiling the potential of prohibitin in cancer.

W. Jiang, S. Koushyar, D. A. Dart, 2015, Cancer letters.

Current advances in the inhibition of the auto-regulatory interaction between the p53 tumour suppressor protein and MDM2 protein

S. Picksley, D. Dart, Maqsood S Mansoor, 2001 .

FUS/TLS is a novel mediator of androgen-dependent cell-cycle progression and prostate cancer growth.

B. Spencer‐Dene, C. Robson, D. Mann, 2011, Cancer research.

Androgen-regulated processing of the oncomir miR-27a, which targets Prohibitin in prostate cancer.

P. Rennie, A. Sita-Lumsden, C. Fletcher, 2012, Human Molecular Genetics.

Prostate-specific PTen deletion in mice activates inflammatory microRNA expression pathways in the epithelium early in hyperplasia development

W. Jiang, W. Jiang, P. Uysal-Onganer, 2017, Oncogenesis.

Circulating nucleic acids as biomarkers of prostate cancer.

J. Waxman, A. Sita-Lumsden, C. Fletcher, 2013, Biomarkers in medicine.

The role of p53 in the chemotherapeutic responses to cisplatin, doxorubicin and 5-fluorouracil treatment.

S. Picksley, D. Dart, P. Cooper, 2004, International journal of oncology.

Circulating microRNAs as potential new biomarkers for prostate cancer

J Waxman, J. Waxman, A Sita-Lumsden, 2013, British Journal of Cancer.

Recruitment of the Cell Cycle Checkpoint Kinase ATR to Chromatin during S-phase*

N. Lakin, D. A. Dart, I. Akerman, 2004, Journal of Biological Chemistry.

Prohibitin, a protein downregulated by androgens, represses androgen receptor activity

D. Dart, S. Gamble, J. Waxman, 2007, Oncogene.

Discovery of deshydroxy bicalutamide derivatives as androgen receptor antagonists.

D. Dart, L. Davies, A. Westwell, 2019, European journal of medicinal chemistry.

Recruitment of ATR to sites of ionising radiation-induced DNA damage requires ATM and components of the MRN protein complex

N. Lakin, A. Medhurst, D. A. Dart, 2006, Oncogene.

Manipulating prohibitin levels provides evidence for an in vivo role in androgen regulation of prostate tumours

B. Spencer‐Dene, S. Gamble, J. Waxman, 2009, Endocrine-related cancer.

MicroRNA-1 acts as a tumor suppressor microRNA by inhibiting angiogenesis-related growth factors in human gastric cancer

W. Jiang, J. Ji, Xiaofang Xing, 2017, Gastric Cancer.

Mechanisms of androgen receptor repression in prostate cancer.

S. Gamble, C. Bevan, G. Brooke, 2006, Biochemical Society transactions.

Wnt-11 Expression Promotes Invasiveness and Correlates with Survival in Human Pancreatic Ductal Adeno Carcinoma

W. Jiang, D. Dart, C. Hao, 2019, Genes.

Novel Trifluoromethylated Enobosarm Analogues with Potent Antiandrogenic Activity In Vitro and Tissue Selectivity In Vivo

D. Dart, A. Westwell, Wenguo Jiang, 2018, Molecular Cancer Therapeutics.

AR mRNA stability is increased with AR-antagonist resistance via 3′UTR variants

W. Jiang, W. Jiang, D. Dart, 2019, Endocrine connections.

Overexpression of Activin Receptor-like Kinase 7 in Breast Cancer Cells Is Associated with Decreased Cell Growth and Adhesion.

F. Su, D. Dart, Wenguo Jiang, 2017, Anticancer research.

Prohibitin Links Cell Cycle, Motility and Invasion in Prostate Cancer Cells

P. Uysal-Onganer, S. Koushyar, D. A. Dart, 2023, International journal of molecular sciences.

Reducing prohibitin increases histone acetylation, and promotes androgen independence in prostate tumours by increasing androgen receptor activation by adrenal androgens

J. Waxman, A. Sita-Lumsden, C. Bevan, 2011, Oncogene.

Prostate Cancer Cell Extracellular Vesicles Increase Mineralisation of Bone Osteoblast Precursor Cells in an In Vitro Model

A. Clayton, J. Webber, P. Uysal-Onganer, 2021, Biology.

Interplay between steroid signalling and microRNAs: implications for hormone-dependent cancers.

C. Fletcher, C. Bevan, D. A. Dart, 2014, Endocrine-related cancer.

Androgen-regulated processing of the oncomir miR-27a, which targets Prohibitin in prostate cancer.

P. Rennie, A. Sita-Lumsden, C. Fletcher, 2012, Human molecular genetics.